The way it was explained to me is that there is a low level of psa that is always present in the system. This test is also called a Total psa test. The total or free psa test helps the doctor to set a baseline from where the other psa tests are measured from. My psa level was at .80 and shifted up to a 1.25, by that time I was already in The PSA test measures the amount of prostate-specific antigen in the blood. The larger a man's prostate, the more PSA he produces. Elevated levels can point to cancer. Among men whose PSA levels increased one point or less, 10.3% of those taking dutasteride had aggressive cancer, compared with 5.4% taking a placebo. In end of study cases PSA increased annually by 6% (placebo) and 7% (finasteride). In those with interim diagnoses PSA increased by 11% (placebo) and 15% (finasteride) each year prior to diagnosis. Cases with high grade disease (Gleason 7 and above) had greater PSA increases than cases with low grade disease (p <0.001). The prostate creates a protein, the prostate-specific antigen, or PSA. A PSA screening test is a blood test approved by the FDA in 1994 to measure the levels of PSA in a mans blood. However, highly elevated PSA total with low free PSA levels is a strong prostate cancer marker and a result required fast medical decision.Elevated High PSA Purpose: We demonstrate the effect of chronic inflammation of the prostate on the ratio of free-to-total prostate specific antigen (PSA) in serum calculated as a percentage of free PSA and, therefore, that percentage of free PSA is an unspecific means to distinguish among prostate cancer, chronic prostatitis and benign prostatic hyperplasia (BPH). One study in 66 men with BPH found saw palmetto supplements to be more effective at lowering levels of prostate-specific antigen (PSA) The capsules are vegan-friendly and free of major The prostate-specific antigen (PSA) test is a screening test for prostate cancer, as well as a method for monitoring the treatment of the disease and testing for recurrence.Like other early detection cancer screening tests, it is designed to alert a person to the presence of disease before any symptoms occur. At the current time, most prostate cancers are detected in this way, via this blood INTRODUCTION. Prostate-specific antigen (PSA) measurement in patients with serum PSA level above 4.0 ng/mL has a sensitivity of about 20%, and the specificity of PSA measurements is approximately 60% to 70% at this cut-off ().If patients with PSA levels below 10 ng/mL were submitted to prostate biopsy, 20-40% would be diagnosed with prostate cancer and 60-80% should undergo unnecessary PSA is a protein produced mainly by cells in the prostate gland and can be a useful indicator of prostate cancer. This protein can be found in all people with a prostate; however raised levels may indicate an infection of the prostate gland (prostatitis), benign prostate enlargement or prostate cancer. In blood, PSA is present both as free PSA Free PSA (fPSA): As low as 5-35% of circulating PSA levels are found free without binding to any protein. Free PSA in this way is known as "free PSA". Free PSA/total PSA ratio: f PSA levels decrease in patients with prostate cancer. If the %f PSA rate is 10%, it means 56% of these patients, and if it is 25%, 8% of the patients have prostate jVTx.